TOMI Environmental Solutions Inc. (TOMZ)

[gigem95]

Welcome, and congratulations. It is definitely undervalued, and I believe it will be moving up again soon.

GLTU! TOMZ

[shermann7]

It looks lik TOMZ has bottomed and is certainly way undervalued ..

I picked up my first 500 shares today ...

GLTA - Shermann

[gigem95]

At one time I didn't think we'd get the full value out of a buyout. But now I would welcome it in a heartbeat!

[wickerman]

I know Pfizer wouldn't mind owning them.

[gigem95]

Exactly, I don't get it. I'm hoping that one day others will see the potential here, but it seems like it's a secret unfortunately.

[wickerman]

$TOMZ just another 10% drop on great news this stock is mind boggling.

[gigem95]

I still have faith that the true value of this stock will be realized eventually, although this is hard to watch on a daily basis.

[19 Road Glide Special]

Not sure gig, disappointing for sure. Starting to smell like the "Big D", and I don't mean Dallas.

[gigem95]

Nice news, but unfortunately followed by plenty of selling and a lower pps so far. What will it take to get TOMZ up to it's true potential?

[19 Road Glide Special]

News Out-->


FREDERICK, Md. , Nov. 18, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ:TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). As a part of TOMI’s ongoing effort to advance its products and technology, it has continued to expand intellectual property protection of its innovative disruptive technology. TOMI is pursuing patent rights in diverse regions of the world, encompassing the United States , the European Union , Brazil , Mexico , Korea , China , India and many other countries.

TOMI has now received its registration from The Australian Register of Therapeutic Goods (ARTG) through its Australian partner, Melbourne -based LAF Technologies (Laftech), a leading provider in Australia specializing in controlled environment systems and contamination control equipment for the past 33 years. Further, TOMI is also proud to report issuance of a first Australian patent protecting use of its ionized Hydrogen Peroxide (iHP) technology; TOMI continues to pursue additional patent protection for its technologies in Australia . This development complements the recent allowance in Israel of TOMI’s patent application covering iHP technology; an Israeli patent will issue in the near future.

TOMI is also developing international intellectual property protection in various areas, such as decontamination of small enclosures or food decontamination. Recent patent publications include U.S. and international applications regarding food decontamination (US2020/0345021 and WO2020/223661); and published applications in India for decontamination methods using iHP technology and for small enclosures.

TOMI now has over forty (40) patents around the world, with an even greater number of patent applications being currently prosecuted worldwide. In addition, TOMI has been approved for over fifty-five (55) trademarks including registrations in over five (5) classes with more than one hundred-twenty (120) trademark applications pending approval globally. TOMI is continuing to submit additional patent and trademark applications to secure intellectual property protection in new product lines being introduced.

Elissa J. (E.J.) Shane , Chief Operations Officer of TOMI stated: “Intellectual property has remained a vital component for TOMI as we continue to expand SteraMist technology. SteraMist iHP technology is vastly different than any other disinfection technology on the market, making the efforts and diligence behind protecting our intellectual property of paramount importance.”

TOMI™ Environmental Solutions, Inc. : Innovating for a safer world® 
TOMI™  Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense , BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association , The American Association of Tissue Banks , Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America , America Seed Trade Association , and The Restoration Industry Association .
For additional information, please visit http://www.tomimist.com/ or contact us at [e-mail].
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.
INVESTOR RELATIONS CONTACT Harold Paul [e-mail]

[timmyc10]

Newsmax National Report Interviews Dr. Halden Shane about SteraMist: https://t.co/r827Z9bCR4 #SteraMist $TOMZ

— SteraMist (@TOMIMist) November 17, 2020

Today’s Newsmax interview with CEO Dr. Halden Shane

[timmyc10]

73 hospitals using currently. Nice Pfizer name drop.

[krisc62]

CEO is on now!

[timmyc10]

CEO live on Newsmax at 11:40 AM EST

[timmyc10]

I am no accountant but their 10-Q shows Total Operating Expenses for the first three quarters of 2020 at $5.4M .. Maybe round up and call it $10M for the year. The CEO mentioned a 2021 operating budget of +$38M on last week’s call. Things are set to scale massively. This is stealing at $5

[wickerman]

$TOMZ basically a $9 stock trading for under $5

Financial Results for the Three Months Ended September 30, 2020 compared to September 30, 2019

Total net revenue was $4,292,000 compared to $1,600,000, representing an increase of $2,692,000, or 168%.
SteraMist® equipment-based revenues was $2,945,000 and $669,000, respectively, representing an increase of $2,276,000 or 340%
SteraMist® BIT Solution-based revenues was $732,000 and $259,000, respectively, representing an increase of $473,000 or 183%
Service-based revenue was $615,000 and $672,000, respectively, representing a decrease of $57,000 or 8%.
Domestic revenue was $3,446,000 and $1,288,000, respectively, representing an increase of $2,158,000, or 168%.
International revenue was approximately $846,000 and $312,000, respectively, representing an increase of $534,000 or 171%.
Gross margins were 66.1% compared to 71.3%. The lower gross profit is attributable to the product mix in sales.
Income from operations was $1,096,000, compared to a Loss from operations of ($188,000), representing an increase of $1,284,000.
Net Income was $1,019,000, or $0.06 on a per share basis compared to a Net loss of ($237,000), or ($0.02) on a per share basis, representing an increase of $1,256,000.
EBIDTA was $1,274,000 compared to an adjusted net loss of ($5,000). A table reconciling EBITDA to the appropriate GAAP measure is included with the Company's financial information below.
Cash provided from operations for the nine months ended September 30, 2020 and 2019 of $4,945,000, compared to cash used in operations of ($573,000), respectively.
Balance sheet highlights as of September 30, 2020 and December 31, 2019

Cash and cash equivalents of approximately $5,885,000 and $897,000, representing an increase of $4,988,000.
Working capital of $11,692,000 and ($1,266,000), representing an increase of $12,958,000.
Shareholders’ equity of $13,251,000 and $890,000, representing an increase of $12,361,000.
Current Business Highlights To Date
Revenues

Milestone reached in the third quarter of 2020 with total revenues exceeding $21 million in a calendar year.
Year over year growth in overall revenue through September 30th of $16,882,000 or 376%.
Year over year growth SteraMist® equipment revenue through September 30th of $13,165,000 or 456%.
Year over year growth SteraMist® BIT Solution revenue through September 30th of $2,931,000 or 509%.
Year over year growth in service revenue through September 30th of $786,000 or 76%.

https://www.biospace.com/article/releases/steramist-continues-to-provide-proven-regulated-disinfection-for-covid-19-and-other-pathogens/#:~:text=Coronavirus%20and%20COVID%2D19%20has,resistant%20pathogens%20known%20to%20mankind.

https://tomimist.com/

[gigem95]

You are spot on here WM. They need to recognize that they can't do everything, and let the people who are specialized take over those jobs...PR, IR, sales, etc. This company has the potential to do so much better, and I'm hoping that this is a wakeup call to make that happen. Unfortunately, I've said something similar after the last 3 conference calls now.

GLTU!

[wine maker]

GIG 95
I am not selling anytime soon. I was wrong about inventories being replenished after the Q1 initial purchases. It all boils down to old men running the company w/o a clue on how to use media. I am 73 myself and I realize that I am not as sharp as my 32 and 29 yr. old kids. Sharp thinking young executives w/ jobs like Instacart.
I think that the executives were happy for yrs. schlepping along w/ nice salaries and never thought about taking the $ and hiring professional media. My wife a # of yrs. ago paid ( $4K a month ) to a professional media lady to market her Sonoma wine country property and it worked w/ great stories in major publications. If we are infact sitting on $12 million in free cash then $10K a month is chicken feed. Very frustrated for my being so stupid and tying up capital that could have worked better in the last 9 months. Maybe these boys will pull the finger out and produce real sales and not hot dog stand sales results.

[gigem95]

[gigem95]

Very good points here 19 RGS. I think using a PR firm will bring a lot of positive exposure to Tomi, and a lot of us have suggested it for some time now.

Your concern about a sales team was brought up by me as well, and I suggested that they hopefully have a young, hungry sales team working for them to bring in new business. Harold did say there was a sales team buildout, which is good. I don't know how aggressive they have been in the past in cultivating new business, but hopefully that will change asap.

GLTU! TOMA

[gigem95]

I sent an email to Harold and the [e-mail] address after the conference call, and heard back from Harold fairly quickly yesterday. I'm not going to copy it here, but I let them know how displeased many of us are with the numbers yesterday (and the last 3 quarterly's, and the selloff in after hours. I know that Dr. Shane doesn't really pay attention to the stock price, but as a public company that is something they need to be concerned with.

To paraphrase, Harold replied that replied that they too were disappointed with the numbers, although that as things played out during the quarter they actually exceeded their expectations. I'm not sure how true this statement was. He did say that the pipeline is robust and outlook is positive.

I'm not going to sell anytime soon, and still believe that Tomi is undervalued, and that the numbers will soon catch up. Unfortunately it's hard to watch the slide we've had after each of the last 3 earnings releases.

[19 Road Glide Special]

TC10: As usual, agree with your opinion and comments. I was encouraged to hear that they are hiring a "Professional" IR firm. I only hope that their opinion of an "Professional" IR firm is not just another Harold Paul who thinks his only job as IR is to maybe answer and email, or get half-hearted, no substance PR's out from time to time.

The keys to growth and PPS increase are simple:

If they claim their clients who need a proven COVID disinfection solution in the midst of a pandemic and don't have funding to do so..... FIND NEW CUSTOMERS (US Government comes to mind). As I stated yesterday, there are BILLIONS of dollars allocated for COVID solutions, yet we only managed to tap $4.3MM of that motherlode in Q3. Get an experienced, targeted Sales staff and aggressively pursue customers who DO have the desire and the financial wherewithal to buy, and buy big. Shane said himself they are just "doing it themselves". Sounds to me like they are hoping word of mouth is going to get them to the promised land....it is very apparent it will not.

Secondly, this new IR firm needs to be just that: Investor Relations. The role is much bigger that answering shareholder questions and putting out PR's. They have to drive interest in the company and increase our visibility on the NAS. Get in the face of some of these institutional investors who have the capital to really invest. Hoping for an increase in value and PPS through retail just isn't going to do it, IMO.

Lastly, They better be careful with how they use that $50MM shelf registration. Regardless of what they use it for, it is a dilutive event. So when they do start to use it, they better be well prepared to explain exactly what the offering is going to be used for and it better be directly tied to something building the company. Without that, we can prepare for another free-fall, IMO.

G/L

[wine maker]

T10,
My email to Harold this AM.

Harold,
A giant FLAT TIRE . I should have sold in August. I guess that I was having unrealistic expectations. Do you think that shareholders are happy w/ these dismal stats? GRIM .

PS. An interview on TD Ameritrade is not enough. We need national exposure. Maybe we need to hire professional media/PR staffing and line up interviews/ demonstrations on business channels like CNBC, Fox Business or Bloomberg. Remember the stock has dropped how many $'s per share in the last months ! Too many excuses by Shane.


Lee Burns
SF

[eom7]

If this volume keep up, we could run today.

looks like we are clearing out the last of the convertible shares...

[timmyc10]

paying an expense price for visibility. This will creep back to $5+ and recover fully with news. Hopefully they ripped the bandaid off and will finally get attention from analysts and institutions. It’s a long term play for sure. Their expansion is evident.

[19 Road Glide Special]

Not the way I wanted to see it happen, but that S#*t show yesterday sure brought in the volume, lol. 420K shares traded in first 20 minutes.

Gotta laugh or you'll cry watching the crew of monkeys running this company.

[eom7]

I think we selloff early and close in the 5's. 4 is probably a great buy.

[rstar]

just listened to cc. sounded like they are frustrated w waiting on fda approval for the sanitizing of ppe

there was also mention of high profile client/partner in the food safety

and new IR being hired , lots of interviews- new product sterapac - sure quarter over quarter revs were down- but the bigger picture here looks very good and stock is oversold in the 4s

[eom7]

Did they say anything about FDA?

[rstar]

9 mos eps .44, the quarter revs were less than last so i see we got whacked on that- but looking like will be ~or over .50 eps for the year. worth more than just 10 p/e imo!
theres also been rotation out of covid stocks w the vaccine but revs are revs- we will just need to see them keep up this level and grow. approval for food would also be a major catalyst.

[Imfeelnlucky]

Well, I know the Covid is certainly ramping up again. And winter isn't going to make it better. Perhaps the climb in PPS happens over the winter.

No matter how we slice it, this sell off hurts.

[gigem95]

In Q2 we had $10 million in revenues, and the expectation was higher, thereby creating a selloff. In Q3 they show $4.3 million, which is a record from Q3 of 2019, but quite a bit less than the previous quarter. I know I was expecting $6-8 million for the quarter, and felt it was conservative. This company has a ton of potential, but is underachieving right now.

I think all shareholders need to write to the company and let them know how we feel.

[wine maker]

IM,
This guy is an idiot. If Covid -19 is less dangerous then less companies will need the service and less salesmen. The salesman should have been traveling like the rest of us to potential customers. Travel was not shut down 100%. What a lame excuse.

[Imfeelnlucky]

What the fuck just happened? Numbers are good, they're adding cash. YoY is great, I don't understand the harsh sell off? Someone can help me understand?

[gigem95]

This conference call and the Q/A session is a joke. Attacking a shareholder who is asking a question about revenue is not acceptable. You are a publicly traded company and have an obligation to create and maintain shareholder value, which the company clearly has not been doing.

[bigone]

They seem to have such potential.......

[gigem95]

I think we all know they need new mgmt, but don't see that happening anytime soon. I too regretted holding through Q2, and debated doing it again. However, I set my expectations lower and felt that if we hit $6-8 million in revenues we would be ok. I guess I should have set my expectations lower. Had management told me they expected $4.3 million or less for the quarter, I definitely would not have held. I'm glad they "exceeded their expectations" for the quarter. Clueless!

GLTU!

[gigem95]

I'm not sure why I bother joining the conference call, it's just a bunch of numbers and highlights that are read verbatim off of a printout by the most boring narrator ever. I'd rather just read it for myself in a PR.

[wine maker]

GIG 95,
You are spot on . Need new young mgt. Very profitable as a % but where are the stellar sales. I should have sold before Q2 Conf. Call. ENPH has risen from $40. to $120. I think that I need to go to church and pray for a financial miracle. I am lucky that my avg. PPPS is low but at least give me a slight profit. Old men talking w/ no idea as to how to get on CNBC business and capture 10 million eyes and more customers.

[HokieHead]

Impossible at this point. Maybe they need to lose money to get a higher stock price lol.

[Inspector121]

HH. Care to make any predictions here?

[gigem95]

After seeing the selloff after Q2 was released, this seems about right. I'm holding much longer, although it's tough to see this get driven down so low right now. I feel bad that I talked my Dad into putting some money into this before the Q2 numbers came out. I can't even stand to listen to Dr. Shane talk any longer! And if I have to listen to him say Steri-mist once more...UGH! Someone ask him how Steramist is pronounced that way. Lol.

I agree that this is worth so much more than what the shares are selling for, but unfortunately the rest of the market doesn't see it that way.

[gigem95]

The revenues of $4.3 million for the quarter exceeded their expectations? They just don't get it. The opportunity is here, and they need to work harder to capitalize on quarter after quarter growth, not for year to year quarterly growth.

IMO they need to get new, younger executive management, who are hungry to grow this company and take advantage of this unfortunate, but once in a lifetime situation for this company. They have a great product that could sell itself to a tune of $4.3 million a quarter with little to no effort. With some effort they should be hitting $10 million plus every quarter.

GLTA! TOMZ

[HokieHead]

9 months sales 2020 -> $21 million
9 months sales 2019 -> $4 million

9 months Net Income 2020 -> $7.3 million
9 months Net Income 2019 -> ($1.7 million)

They earned $0.40 a share. A 25 PE = $10 a share..

A 25% selloff? Incredible..

[19 Road Glide Special]

So their Q3 revenue was down due to financial difficulties of their customers brought on by the pandemic??????? There are BILLIONS of dollars being spent on technology to fight this virus. TOMI cant find some of that?

Please.

[HokieHead]

I think we will hear the business was run in this quarter by scammers that took some of their business. They are the only EPA certified product, the rest will get shut down, all business will come here imo. Will be interesting to hear the call.

[19 Road Glide Special]

Just doesn't make sense in the midst of a raging pandemic that they couldn't muster sales in excess of $4.3MM. I guess we know why they were so stingy with the PR.....apparently there was nothing to talk about.

Unbelievable.....

[HokieHead]

I wonder if that’s what happened, will be interesting to hear on the call. If the other so called “competition” is getting shut down that could set TOMZ up for large quarters to come again going forward. Insane at $5 it’s only valued at $75-$80 million. Definitely a takeover target here.

[HokieHead]

Revenues were down from last quarter could be the issue but the company is in a strong financial position. Crazy imo.

Balance sheet highlights as of September 30, 2020 and December 31, 2019
- Cash and cash equivalents of approximately $5,885,000 and $897,000, representing an increase of $4,988,000.
- Working capital of $11,692,000 and ($1,266,000), representing an increase of $12,958,000.
- Shareholders’ equity of $13,251,000 and $890,000, representing an increase of $12,361,000.

[BPETER]

Oops are we overlooking something ???